DYSPORT™ is an acetylcholine release inhibitor and a neuromuscular dysport-botox-logoblocking agent indicated for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position and neck pain in both toxin-naïve and previously treated patients.
DYSPORT™ Important Safety Information
Distant Spread of Toxin Effect
The effects of DYSPORT™ and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.

Immediate medical attention may be required in cases of respiratory, speech or swallowing difficulties.

The dosing units of DYSPORT™ are not the same as other botulinum toxin products and therefore are not interchangeable with other preparations of botulinum toxin products.

DYSPORT™ should be administered in accordance with the labeling instructions, and the recommended dosage and frequency of administration should not be exceeded.

Patients with a neuromuscular disorder of the nerve-muscle junction may be at increased risk of side effects.

Caution should be exercised when administering DYSPORT™ to patients who have surgical changes to their faces, drooping eyelid folds, deep facial scars, or thick oily skin.

To learn more about Dysport, visit the Dysport FAQ page